Neola Medical AB (OSTO:NEOLA) Total Equity: kr75.80 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:NEOLA Neola Medical AB OSTO:NEOLA
28 GF Score
Price kr0.68
! 1 Warning Sign
View Full Analysis

What is Neola Medical AB Total Equity?

Neola Medical AB OSTO:NEOLA -1.45% 28 Total Equity is kr75.80 Mil as of Dec. 2025. GuruFocus rates OSTO:NEOLA with a GF Score™ of 28/100. The stock has 1 warning sign investors should review.

Neola Medical AB's total equity for the quarter that ended in Dec. 2025 was kr75.80 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Neola Medical AB Total Equity Historical Data

* Premium members only.

The historical data trend for Neola Medical AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neola Medical AB Total Equity Chart

Neola Medical AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 40.63 67.49 79.03 68.96 75.80

Neola Medical AB Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.96 84.21 81.22 78.46 75.80
OSTO:NEOLA
28GF Score
Neola Medical AB OSTO:NEOLA
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neola Medical AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Neola Medical AB's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=78.802-2.999
=75.80

Neola Medical AB's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=78.802-2.999
=75.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of kr75.80 Mil mean?
Neola Medical AB (OSTO:NEOLA) has a Total Equity of kr75.80 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Neola Medical AB and its competitors.
Is Neola Medical AB's Total Equity too high?
Neola Medical AB's current Total Equity is kr75.80 Mil. Overall, Neola Medical AB has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Neola Medical AB's Total Equity compare to ABT and SYK?
Neola Medical AB's Total Equity of kr75.80 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Neola Medical AB and its competitors. Neola Medical AB's current Total Equity is kr75.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neola Medical AB stock overvalued right now?
Neola Medical AB (OSTO:NEOLA) has a current Total Equity of kr75.80 Mil. The current Total Equity is kr75.80 Mil. Neola Medical AB's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Neola Medical AB (OSTO:NEOLA), the current Total Equity is kr75.80 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neola Medical AB Business Description

Address Scheelevagen 27, Ideon Science Park, Gateway 9th fl oor, Lund, SWE, 223 63
Neola Medical AB is revolutionizing neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a technology that measures lung volume changes and oxygen gas concentration. NEOLA has the potential to provide care, fewer days in intensive care, and healthier lives for preterm born infants. The company is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to health care.
28GF Score

Get the complete analysis for OSTO:NEOLA

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.68
Price